Summary

  ㅁ Title: The 1st Meeting on Access to Medicines under Universal Health Coverage in the Asia Pacific Region
  ㅁ Date: 18 – 19 September 2014
  ㅁ Venue: Prima Hotel, Seoul, Korea
  ㅁ Hosted by OECD Korea Policy Centre (Health and Social Policy Programme), WHO WPRO,

       WHO Collaborating Centre (SNU),

  ㅁ Participation: 34 persons
     ㅇ Pharmaceutical policy experts from the Asia Pacific countries
     ㅇ International Organizations: OECD, WHO WPRO, GIZ
 

  Programme Summary

         ㅁ 18 September 2014

              Congratulatory Remarks
         - Sang Woo Nam, Executive Secretary of OECD Korea Policy Centre

       Session I. Key Issues in Pharmaceutical Policy and Financing
         1. Pharmaceutical policy in Asia and the goals of the meeting
            - Presentation by Klara Tisocki (WHO WPRO)
         2. Pharmaceutical policy in OECD countries
            - Presentation by Annalisa Belloni (OECD)
         3. Pharmaceutical financing in Asia
           - Presentation by Soonman Kwon (Seoul National Univ. and WHO Collaborating Centre)

       Session II. Pharmaceutical Policy and financing in Asia and the Pacific
         1. Pharmaceutical expenditure and utilization (Chair: Prastuti Soewondo)
            - Presentation by Luca Lorenzoni (OECD)

                   - Country presentations (Cambodia, Mongolia)
         2. Financing and benefit package (Chair: Taejin Lee)
            - Country presentations (Indonesia, Philippines, Thailand)
         3. Pricing and reimbursement (Chair: Dennis Ross-Degnan)
            - Country presentations (Australia, Korea, Singapore)

                4. Other key issues (e.g. rational use, procurement, quality (Chair: Libby Roughead)
            - Country presentations (Laos, Malaysia, Vietnam)

  ㅁ 19 September 2014

              Session III. Discussions and the Finalization of Template
         1. Group discussions on the templates
            - 4 groups (Chairs: Philippines, Malaysia, Thailand, Singapore)
         2. Reports from groups and discussions (Chair: Soonman Kwon)

                3. The progress of Pharmaceutical Pricing and Reimbursement Policy (PPRI) Network by Sabine Wogler

                   (PPRI, Europe) and Discussions

              Session IV. Future Plans / Chair: Klara Tisocki